Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    - Updated revision from v3.1.0 to v3.2.0, and added government operating-status notice and a new topic link (Multiple myeloma) for MedlinePlus Genetics. The prior revision notice was removed (v3.1.0 deleted) in favor of v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T16:07:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Updated the page to use a unified term Multiple myeloma with a new revision tag v3.1.0, replacing older related topics and the older revision v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-29T10:09:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Multiple myeloma, expanding core content about a disease and its genetics.
    Difference
    0.2%
    Check dated 2025-09-22T05:42:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2. It removes the MedlinePlus Genetics topic on Multiple myeloma and the older v3.0.1 entry (as well as the Back to Top link).
    Difference
    0.4%
    Check dated 2025-09-15T01:08:56.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to include information on 'Multiple myeloma' under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.4%
    Check dated 2025-09-07T21:18:01.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location related to plasma cell myeloma and hemic and lymphatic diseases, while several specific location details and drug information have been removed.
    Difference
    2%
    Check dated 2025-08-31T19:35:46.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.